Literature DB >> 8040262

Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines.

F O Nestle1, L A Turka, B J Nickoloff.   

Abstract

Local activation of T lymphocytes is regarded as an important immunological component of psoriatic skin lesions. Within psoriatic plaques (PP) there are large numbers of dermal dendritic cells (DDCs) immediately beneath the hyperplastic epidermis surrounded by T cells. In this study we investigated the ability of DDCs isolated from PP skin to support immune responses to resting peripheral blood T cells. For comparison, other dendritic cells were obtained from blood of the same psoriatic patients, as well as DDCs from skin of normal healthy individuals (designated NN skin). All dendritic cells studied had high surface expression of HLA-DR, B7, and lymphocyte function associated antigen-1 molecules. T cell proliferative responses and cytokine production profiles to these various dendritic cells were measured in the absence and presence of PHA or bacterial-derived superantigens. In the absence of exogenous mitogens, PP skin-derived DDCs were much more effective stimulators of spontaneous T cell proliferation compared with either psoriatic blood-derived or NN skin-derived dendritic cells. Antibody blocking studies revealed involvement of HLA-DR, B7, and lymphocyte function associated antigen-1 on PP skin-derived DDCs. Cytokine profiles revealed that in the absence of exogenous stimuli PP skin-derived DDCs mediated a T cell response with high levels of IL-2 and IFN-gamma, but not IL-4 or IL-10. NN skin-derived DDCs produced a similar qualitative response, but quantitative amounts of all cytokines measured were lower. Upon addition of PHA or superantigens, both PP skin-derived and NN skin-derived DDCs mediated high levels of IL-2 and IFN-gamma production, with induction of IL-4 particularly evident for PHA reactions. Addition of conditioned medium from psoriatic dermal fragments did not enhance the autostimulatory capacity of blood-derived dendritic cells. These findings highlight the potent autostimulatory potential of PP skin-derived DDCs and suggest an important immunological contribution for these previously overlooked cell types contained within lesional skin sites.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8040262      PMCID: PMC296298          DOI: 10.1172/JCI117308

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets.

Authors:  F O Nestle; X G Zheng; C B Thompson; L A Turka; B J Nickoloff
Journal:  J Immunol       Date:  1993-12-01       Impact factor: 5.422

2.  Psoriasis induced at the injection site of recombinant interferon gamma. Results of immunohistologic investigations.

Authors:  G Fierlbeck; G Rassner; C Müller
Journal:  Arch Dermatol       Date:  1990-03

3.  Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin.

Authors:  R Cerio; C E Griffiths; K D Cooper; B J Nickoloff; J T Headington
Journal:  Br J Dermatol       Date:  1989-10       Impact factor: 9.302

4.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.

Authors:  T R Mosmann; H Cherwinski; M W Bond; M A Giedlin; R L Coffman
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

5.  Cellular autoimmunity in psoriasis and lichen planus.

Authors:  D Steinmuller; A R Zinsmeister; R S Rogers
Journal:  J Autoimmun       Date:  1988-06       Impact factor: 7.094

6.  Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells.

Authors:  M D Witmer-Pack; W Olivier; J Valinsky; G Schuler; R M Steinman
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

7.  Tumor necrosis factor alpha maintains the viability of murine epidermal Langerhans cells in culture, but in contrast to granulocyte/macrophage colony-stimulating factor, without inducing their functional maturation.

Authors:  F Koch; C Heufler; E Kämpgen; D Schneeweiss; G Böck; G Schuler
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

8.  Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro.

Authors:  G Schuler; R M Steinman
Journal:  J Exp Med       Date:  1985-03-01       Impact factor: 14.307

9.  Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution.

Authors:  R M Steinman; Z A Cohn
Journal:  J Exp Med       Date:  1973-05-01       Impact factor: 14.307

10.  Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells.

Authors:  C Heufler; F Koch; G Schuler
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

View more
  66 in total

1.  CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris.

Authors:  J R Abrams; M G Lebwohl; C A Guzzo; B V Jegasothy; M T Goldfarb; B S Goffe; A Menter; N J Lowe; G Krueger; M J Brown; R S Weiner; M J Birkhofer; G L Warner; K K Berry; P S Linsley; J G Krueger; H D Ochs; S L Kelley; S Kang
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

Review 2.  Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities.

Authors:  Brian J Nickoloff; Frank O Nestle
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

Review 3.  Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: a review and analysis of 36 cases.

Authors:  M Afshar; A D Martinez; R L Gallo; T R Hata
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-06-01       Impact factor: 6.166

Review 4.  Animal models of psoriasis and psoriatic arthritis: an update.

Authors:  Curdin Conrad; Frank O Nestle
Journal:  Curr Rheumatol Rep       Date:  2006-10       Impact factor: 4.592

5.  Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation.

Authors:  Hideaki Sugiyama; Rolland Gyulai; Eiko Toichi; Edina Garaczi; Shinji Shimada; Seth R Stevens; Thomas S McCormick; Kevin D Cooper
Journal:  J Immunol       Date:  2005-01-01       Impact factor: 5.422

Review 6.  Immunopathogenesis of psoriasis.

Authors:  Brian J Nickoloff; Jian-Zhong Qin; Frank O Nestle
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

7.  Cytokine gene transcription of human colonic intraepithelial lymphocytes costimulated with epithelial cells bearing HLA-DR and its inhibition by 5-aminosalicylic acid.

Authors:  D Chen; G Radford-Smith; M C Dipaolo; I McGowan; D P Jewell
Journal:  J Clin Immunol       Date:  1996-07       Impact factor: 8.317

8.  Understanding human myeloid dendritic cell subsets for the rational design of novel vaccines.

Authors:  Eynav Klechevsky; Maochang Liu; Rimpei Morita; Romain Banchereau; Luann Thompson-Snipes; A Karolina Palucka; Hideki Ueno; Jacques Banchereau
Journal:  Hum Immunol       Date:  2009-02-21       Impact factor: 2.850

9.  Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis.

Authors:  D Y Leung; J B Travers; R Giorno; D A Norris; R Skinner; J Aelion; L V Kazemi; M H Kim; A E Trumble; M Kotb
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

Review 10.  Immunology of psoriasis.

Authors:  Michelle A Lowes; Mayte Suárez-Fariñas; James G Krueger
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.